Abigail Sloan

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Instrumental methods (excl. immunological and bioassay methods)Statistical and quantitative genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 09, 2026
Orolabial and Genital Herpes Clinical Trials: A Meta-analysis of Endpoints.

Abigail Sloan, Mahta Mortezavi, Jacqueline Gerhart

|Sep 20, 2024
Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses.

Elena Peeva, Yuji Yamaguchi, Zhan Ye

|Jul 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.

Yuji Yamaguchi, Elena Peeva, Ester Del Duca

|Feb 09, 2024
Combination MCP-Mod for two-drug combination dose-ranging studies.

Yifan Zhou, Abigail Sloan, Sandeep Menon

|Dec 30, 2021
A repeated measures approach to pooled and calibrated biomarker data.

Abigail Sloan, Chao Cheng, Bernard Rosner

|Dec 21, 2018
Design and analysis considerations for combining data from multiple biomarker studies.

Abigail Sloan, Yue Song, Mitchell H Gail

Pageof 1

Frequent Collaborators

2 joint publications

Yuji Yamaguchi

2 joint publications

Ester Del Duca

2 joint publications

Paola Facheris

2 joint publications

Jonathan Bar